• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by The Pennant Group Inc. (Amendment)

    4/6/23 9:29:30 AM ET
    $PNTG
    Medical/Nursing Services
    Health Care
    Get the next $PNTG alert in real time by email
    SC 13G/A 1 us70805e1091_040523.txt us70805e1091_040523.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 6) Pennant Group, Inc. -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 70805E109 -------------------------------------------------------- (CUSIP Number) March 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 70805E109 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 1821927 (6) Shared voting power 0 (7) Sole dispositive power 1851289 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 1851289 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 6.2% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- Pennant Group, Inc. Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 1675 E. RIVERSIDE DRIVE, SUITE 150 EAGLE ID 83616 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 1851289 Percent of class 6.2% Number of shares as to which such person has: Sole power to vote or to direct the vote 1821927 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 1851289 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of Pennant Group, Inc.. No one person's interest in the common stock of Pennant Group, Inc. is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 5, 2023 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Advisors, LLC Aperio Group, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock Investment Management (Australia) Limited BlackRock Fund Advisors BlackRock Asset Management Ireland Limited BlackRock Institutional Trust Company, National Association BlackRock Financial Management, Inc. BlackRock Fund Managers Ltd BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BLACKROCK, INC., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Christopher Meade, Daniel Waltcher, Una Neary, Richard Cundiff, Charles Park, Enda McMahon, Arlene Klein, Con Tzatzakis, Karen Clark, David Maryles, Daniel Ronnen, John Stelley, Daniel Riemer, Elizabeth Kogut, Maureen Gleeson, Daniel Kalish and Spencer Fleming acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, is acting certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, Including without limitation Forms 3, 4, 5, 13D, 13F, 13G and 13H and any amendments to any of the Foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 8th day of December, 2015 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 2nd day of January, 2019. BLACKROCK, INC. By:_ /s/ Daniel Waltcher Name: Daniel Waltcher Title: Deputy General Counsel
    Get the next $PNTG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PNTG

    DatePrice TargetRatingAnalyst
    12/19/2024$33.00Equal Weight
    Wells Fargo
    1/5/2024$14.00 → $18.00Equal-Weight → Overweight
    Stephens
    2/27/2023$15.00 → $16.00Hold → Buy
    Stifel
    8/25/2022$22.00Outperform
    Oppenheimer
    6/21/2022$23.00 → $17.00Overweight → Equal-Weight
    Stephens
    3/10/2022$37.00 → $26.00Outperform
    RBC Capital
    3/2/2022$33.00 → $26.00Overweight
    Stephens & Co.
    3/1/2022$32.00 → $18.00Buy → Hold
    Stifel
    More analyst ratings

    $PNTG
    Leadership Updates

    Live Leadership Updates

    See more
    • The Pennant Group Appoints Suzanne Snapper as Director

      EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

      5/16/25 12:12:47 PM ET
      $ENSG
      $PNTG
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • The Pennant Group Appoints Brent Guerisoli as Chairman and Scott Lamb as Lead Independent Director

      EAGLE, Idaho, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, and senior living companies, today announced the appointment of Brent Guerisoli as Chairman of its board of directors and Scott Lamb as Lead Independent Director of its board of directors, each effective January 1, 2025. Mr. Guerisoli and Mr. Lamb are existing directors of the Company. Mr. Guerisoli has served on Pennant's board since 2023. He has been a key leader with the organization since 2012 and has served as its Chief Executive Officer since 2022. Mr. Guerisoli succeeds Barry Smith, who served as Chairman since February 2

      1/2/25 4:23:29 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • The Pennant Group Appoints Lynette Walbom as Chief Financial Officer

      EAGLE, Idaho, May 22, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that its Board of Directors has appointed Lynette Walbom as Chief Financial Officer effective May 22, 2023. Before joining Pennant, Ms. Walbom was Vice President of Financial Reporting & Tax for Raising Cane's Restaurants, LLC, a national restaurant chain operating in 35 states, which more than doubled in size—based on number of restaurants and geographic footprint—during her tenure. At Raising Cane's, Ms. Walbom had broad responsibility for financial reporting, acquisitions, tax, accou

      5/22/23 4:05:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Pennant Group Appoints Suzanne Snapper as Director

      EAGLE, Idaho, May 16, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced the appointment of Suzanne D. Snapper to its board of directors following her election by a vote of shareholders in connection with the Company's annual shareholder meeting. Ms. Snapper is the Chief Financial Officer of the Ensign Group, Inc. ("Ensign") (NASDAQ:ENSG), a leading publicly-traded provider of skilled nursing services. In this role, which Ms. Snapper has held since 2009, Ms. Snapper is responsible for Ensign's accounting, finance, information technology, tax, internal contro

      5/16/25 12:12:47 PM ET
      $ENSG
      $PNTG
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • Pennant Reports First Quarter 2025 Results

      EAGLE, Idaho, May 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter(1). First Quarter Highlights Total revenue for the first quarter was $209.8 million, an increase of $52.9 million or 33.7% over the prior year quarter;Net income for the first quarter was $7.8 million, an increase of $2.9 million or 58.5% over the prior year quarter;Adjusted net income

      5/6/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Announces First Quarter 2025 Earnings Release and Call

      EAGLE, Idaho, April 21, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its first quarter 2025 financial results on Tuesday, May 6, 2025. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Wednesday, May 7, 2025, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time), during which Pennant's management will discuss its first quarter results. To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the In

      4/21/25 4:27:05 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

      SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

      11/14/24 1:28:33 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Pennant Group Inc.

      SC 13G/A - Pennant Group, Inc. (0001766400) (Subject)

      11/7/24 9:30:29 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G filed by The Pennant Group Inc.

      SC 13G - Pennant Group, Inc. (0001766400) (Subject)

      11/7/24 9:12:22 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Stringfield Joanne sold $17,037 worth of shares (665 units at $25.62), decreasing direct ownership by 2% to 30,275 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      5/5/25 9:35:42 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Chief Operating Officer Gochnour John J exercised 6,286 shares at a strike of $7.42, increasing direct ownership by 5% to 134,250 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      5/1/25 6:45:13 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Director Nackel John G. was granted 1,900 shares, increasing direct ownership by 1% to 165,065 units (SEC Form 4)

      4 - Pennant Group, Inc. (0001766400) (Issuer)

      4/17/25 5:39:12 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Wells Fargo initiated coverage on Pennant Group with a new price target

      Wells Fargo initiated coverage of Pennant Group with a rating of Equal Weight and set a new price target of $33.00

      12/19/24 8:23:12 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Group upgraded by Stephens with a new price target

      Stephens upgraded Pennant Group from Equal-Weight to Overweight and set a new price target of $18.00 from $14.00 previously

      1/5/24 8:40:53 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Group upgraded by Stifel with a new price target

      Stifel upgraded Pennant Group from Hold to Buy and set a new price target of $16.00 from $15.00 previously

      2/27/23 7:37:38 AM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    Financials

    Live finance-specific insights

    See more
    • Pennant Reports First Quarter 2025 Results

      EAGLE, Idaho, May 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.22 for the first quarter of 2025. Pennant also reported adjusted diluted earnings per share of $0.27 for the quarter(1). First Quarter Highlights Total revenue for the first quarter was $209.8 million, an increase of $52.9 million or 33.7% over the prior year quarter;Net income for the first quarter was $7.8 million, an increase of $2.9 million or 58.5% over the prior year quarter;Adjusted net income

      5/6/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Expands Portfolio with Acquisition of Senior Living Community in Arizona

      EAGLE, Idaho, April 01, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces the acquisition of the real estate and operations of an established senior living community in Arizona. The newly acquired community offers assisted living and memory care services, and increases Pennant's Arizona operations by 128 units. "This acquisition aligns with our mission to provide life-changing service as we create active, supportive communities where seniors can thrive," said Brent Guerisoli, Chief Executive Officer of Pennant. "By expanding our services and adding

      4/1/25 4:53:37 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • Pennant Reports Fourth Quarter and Fiscal Year 2024 Results

      Conference Call and Webcast scheduled for tomorrow, February 28, 2025 at 10:00 am MT EAGLE, Idaho, Feb. 27, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results for the fiscal year and fourth quarter of 2024, reporting GAAP diluted earnings per share of $0.70 and $0.16 for the year ended December 31, 2024 and the fourth quarter, respectively. Pennant also reported adjusted diluted earnings per share of $0.94 for the year and $0.24 for the quarter (1). Fourth Quarter Highlights Total revenue for the full year was $695.2 million, an

      2/27/25 4:08:00 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care

    $PNTG
    SEC Filings

    See more
    • The Pennant Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Pennant Group, Inc. (0001766400) (Filer)

      5/20/25 4:08:35 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by The Pennant Group Inc.

      10-Q - Pennant Group, Inc. (0001766400) (Filer)

      5/6/25 4:12:39 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care
    • The Pennant Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Pennant Group, Inc. (0001766400) (Filer)

      5/6/25 4:10:35 PM ET
      $PNTG
      Medical/Nursing Services
      Health Care